CSPC Innovation Pharmaceutical
Market Cap
CN¥7.4b
Last Updated
2021/04/17 09:08 UTC
Data Sources
Company Financials
Executive Summary
CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet with acceptable track record.
Share Price & News
How has CSPC Innovation Pharmaceutical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 300765 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 300765's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
-2.2%
300765
-2.8%
CN Pharmaceuticals
-0.8%
CN Market
1 Year Return
-30.4%
300765
10.4%
CN Pharmaceuticals
25.0%
CN Market
Return vs Industry: 300765 underperformed the CN Pharmaceuticals industry which returned 10.4% over the past year.
Return vs Market: 300765 underperformed the CN Market which returned 25% over the past year.
Shareholder returns
| 300765 | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.2% | -2.8% | -0.8% |
| 30 Day | -5.1% | 1.0% | -0.08% |
| 90 Day | 0.3% | -5.1% | -5.3% |
| 1 Year | -30.2%-30.4% | 11.5%10.4% | 27.0%25.0% |
| 3 Year | n/a | 25.2%20.8% | 29.1%22.8% |
| 5 Year | n/a | 46.5%38.7% | 30.5%21.7% |
Long-Term Price Volatility Vs. Market
How volatile is CSPC Innovation Pharmaceutical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is CSPC Innovation Pharmaceutical undervalued compared to its fair value and its price relative to the market?
24.58x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 300765 (CN¥17.55) is trading above our estimate of fair value (CN¥14.42)
Significantly Below Fair Value: 300765 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 300765 is good value based on its PE Ratio (24.6x) compared to the CN Pharmaceuticals industry average (31.9x).
PE vs Market: 300765 is good value based on its PE Ratio (24.6x) compared to the CN market (33.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 300765's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 300765's PB Ratio (2.8x) is in line with the CN Pharmaceuticals industry average.
Future Growth
How is CSPC Innovation Pharmaceutical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
24.3%
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CSPC Innovation Pharmaceutical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has CSPC Innovation Pharmaceutical performed over the past 5 years?
15.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 300765 has high quality earnings.
Growing Profit Margin: 300765's current net profit margins (22.8%) are higher than last year (21.8%).
Past Earnings Growth Analysis
Earnings Trend: 300765's earnings have grown by 15.8% per year over the past 5 years.
Accelerating Growth: 300765's earnings growth over the past year (9.7%) is below its 5-year average (15.8% per year).
Earnings vs Industry: 300765 earnings growth over the past year (9.7%) underperformed the Pharmaceuticals industry 10.3%.
Return on Equity
High ROE: 300765's Return on Equity (11.2%) is considered low.
Financial Health
How is CSPC Innovation Pharmaceutical's financial position?
Financial Position Analysis
Short Term Liabilities: 300765's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥234.2M).
Long Term Liabilities: 300765's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥33.8M).
Debt to Equity History and Analysis
Debt Level: 300765 is debt free.
Reducing Debt: 300765 has no debt compared to 5 years ago when its debt to equity ratio was 19.2%.
Debt Coverage: 300765 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300765 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is CSPC Innovation Pharmaceutical current dividend yield, its reliability and sustainability?
0.57%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 300765's dividend (0.57%) is higher than the bottom 25% of dividend payers in the CN market (0.44%).
High Dividend: 300765's dividend (0.57%) is low compared to the top 25% of dividend payers in the CN market (1.79%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether 300765's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 300765's dividend payments are increasing as they only just started paying a dividend.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (14%), 300765's dividend payments are thoroughly covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
CEO
CSPC Innovation Pharmaceutical has no CEO, or we have no data on them.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
CSPC Innovation Pharmaceutical Co., Ltd.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: CSPC Innovation Pharmaceutical Co., Ltd.
- Ticker: 300765
- Exchange: SZSE
- Founded: NaN
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: CN¥7.370b
- Shares outstanding: 420.00m
- Website: https://www.xnwpharma.net
Number of Employees
Location
- CSPC Innovation Pharmaceutical Co., Ltd.
- No. 36, Fuqiang Western Road
- Luancheng County
- Shijiazhuang
- Hebei Province
- 51430
- China
Listings
Biography
CSPC Innovation Pharmaceutical Co., Ltd. manufactures and sells caffeine, and vitamin C health supplement and beverage products. The company is based in Shijiazhuang, China. CSPC Innovation Pharmaceutical ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/04/17 09:08 |
| End of Day Share Price | 2021/04/16 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.